Cdc25B Dual-Specificity Phosphatase Inhibitors Identified in a High-Throughput Screen of the NIH Compound Library-Reference-Cited by-同舟云学术

Cdc25B Dual-Specificity Phosphatase Inhibitors Identified in a High-Throughput Screen of the NIH Compound Library

Published:2009-06 Issue:3 Volume:7 Page:250-265
ISSN:1540-658X
Container-title:ASSAY and Drug Development Technologies
language:en
Short-container-title:ASSAY and Drug Development Technologies

Author:

Johnston Paul A.¹²,Foster Caleb A.¹,Tierno Marni Brisson¹,Shun Tong Ying¹,Shinde Sunita N.¹,Paquette William D.³,Brummond Kay M.¹³,Wipf Peter¹³,Lazo John S.¹²

Affiliation:

1. Pittsburgh Molecular Library Screening Center, University of Pittsburgh Drug Discovery Institute, Pittsburgh, Pennsylvania.

2. Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

3. Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania.

Publisher

Mary Ann Liebert Inc

Subject

Drug Discovery,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/adt.2008.186

Reference51 articles.

1. The when and wheres of CDC25 phosphatases

2. CDC25 phosphatases in cancer cells: key players? Good targets?

3. What's new on CDC25 phosphatase inhibitors

4. Targeting PTPs with small molecule inhibitors in cancer treatment

5. Cdc25 Phosphatases and Cancer

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High Throughput Screening Techniques in Anticancer Drug Discovery and Development from Botanicals;Alternative Remedies and Natural Products for Cancer Therapy: An Integrative Approach;2023-10-31

2. Identification of a small RhoA GTPase inhibitor effective in fission yeast and human cells;Open Biology;2023-03

3. A Comprehensive Overview of the Developments of Cdc25 Phosphatase Inhibitors;Molecules;2022-04-07

4. Gains from no real PAINS: Where ‘Fair Trial Strategy’ stands in the development of multi-target ligands;Acta Pharmaceutica Sinica B;2021-11

5. Biological Evaluation of 3-Aminoisoquinolin-1(2H)-one Derivatives as Potential Anticancer Agents Authors Lyudmyla Potikha;French-Ukrainian Journal of Chemistry;2021